马圣宇. 地塞米松联合环孢素治疗老年免疫性血小板减少症的疗效观察[J]. 蚌埠医科大学学报, 2018, 43(5): 606-607,610. DOI: 10.13898/j.cnki.issn.1000-2200.2018.05.012
    引用本文: 马圣宇. 地塞米松联合环孢素治疗老年免疫性血小板减少症的疗效观察[J]. 蚌埠医科大学学报, 2018, 43(5): 606-607,610. DOI: 10.13898/j.cnki.issn.1000-2200.2018.05.012
    MA Sheng-yu. Clinical effect of dexamethasone combined with cyclosporine in the treatment of immune thrombocytopenia in elderly patients[J]. Journal of Bengbu Medical University, 2018, 43(5): 606-607,610. DOI: 10.13898/j.cnki.issn.1000-2200.2018.05.012
    Citation: MA Sheng-yu. Clinical effect of dexamethasone combined with cyclosporine in the treatment of immune thrombocytopenia in elderly patients[J]. Journal of Bengbu Medical University, 2018, 43(5): 606-607,610. DOI: 10.13898/j.cnki.issn.1000-2200.2018.05.012

    地塞米松联合环孢素治疗老年免疫性血小板减少症的疗效观察

    Clinical effect of dexamethasone combined with cyclosporine in the treatment of immune thrombocytopenia in elderly patients

    • 摘要: 目的:探讨大剂量地塞米松联合环孢素治疗老年免疫性血小板减少症(ITP)近期及远期的疗效。方法:将24例老年ITP随机分成对照组12例(地塞米松40 mg/d,4 d),观察组12例(地塞米松40 mg/d,4 d,联合环孢素3 mg·kg-1·d-1)。观察治疗后近期(1周、2周)和远期(1个月)外周血血小板水平及不良反应。结果:治疗前和治疗后7 d 2组血小板水平差异均无统计学意义(P>0.05);治疗后14 d和1个月,观察组血小板水平显著高于对照组(P<0.01);且2组治疗前后不同时刻差异均有统计学意义(P<0.01),2组治疗后7 d、14 d和1个月均显著高于治疗前(P<0.01),而对照组治疗后14 d显著低于治疗后7 d (P<0.01)。2组不良反应差异无统计学意义(P>0.05)。结论:地塞米松联合环孢素能提高老年ITP近期和远期疗效,且不良反应轻微。

       

      Abstract: Objective: To investigate the short and long-term efficacy of high dose dexamethasone combined with cyclosporine in the treatment of immune thrombocytopenia(ITP) in elderly patients.Methods: Twenty-four elderly patients with ITP were randomly divided into the control group(12 cases treated with 40 mg/d of dexamethasone for 4 d) and observation group(12 cases treated with 40 mg/d of dexamethasone for 4 d combined with 3 mg·kg-1·d-1 of cyclosporine).The platelet levels and adverse reactions in two groups were observed after 1 week,2 weeks and 1 month of treatment.Results: The differences of the levels of platelet before,and after 7 d of treatment between two groups were not statistically significant(P>0.05).After 14 days and 1 month of treatment,the levels of platelet in observation group were significantly higher than that in control group(P<0.01),and the differences of the levels of platelet at different time-points between two groups were statistically significant(P<0.01).After 7 d,14 d and 1 month of treatment,the levels of platelet in two groups were significantly higher than that before treatment(P<0.01),and the level of platelet in control group after 14 d of treatment was significantly lower than that after 7 d of treatment(P<0.01).The difference of the adverse reaction between two groups was not statistically significant(P>0.05).Conclusions: The dexamethasone combined with cyclosporine can improve the short-term and long-term efficacy of elderly patients with ITP,and the adverse reaction of which is minute.

       

    /

    返回文章
    返回